Oral Presentations - Session 19 - IMMUNOLOGY & VACCINOLOGY - III
June, 24rd | Time | Oral Presentations |
---|---|---|
09:45 - 10:00 |
(473730) New licensed Mycoplasma hyopneumoniae-based vaccine induce systemic and mucosal immunity and prevent the development of Mycoplasmal Pneumonia in pigs |
|
10:00 - 10:15 |
(459000) Shedding and Transmission of a Lineage One Modified Live Porcine Reproductive and Respiratory Syndrome Virus Vaccine |
|
10:15 - 10:45 | Coffee Break | |
10:45 - 11:00 |
(473196) Study of synergistic action on intestinal integrity of an oral vaccine against Escherichia coli and a ß-mannanase added to the feed |
|
11:00 - 11:15 |
(461333) Prevention of the mucosa-related infectious diseases in piglets |
|
11:15 - 11:30 |
(461498) Construction and Stable Expression of Mammalian Cell-based Secretory Classical Swine Fever Virus Envelope Glycoprotein E2 to Enhance Antigenicity and Performance of Enzyme-linked Immunosorbent Assays |
|
11:30 - 11:45 |
(473787) A bivalent PCV2a-PCV2b vaccine offers biologically superior protection compared to monovalent PCV2 vaccines |
|
11:45 - 12:00 |
(473637) A bivalent vaccine containing PCV2a and PCV2b enhances T-cell epitope coverage against a large and geographically diverse population of recent PCV2 field isolates |